Keyword: Peter Soelkner

Chemistry & Life Sciences

Expert Statement: Thomas Otto and Peter Soelkner, Vetter

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Markets & Companies

Patient Centricity: The New Nexus for CDMOs

11.11.2019 - On the occasion of the pharma trade show CPhI Worldwide 2019, which took place in Frankfurt on November 5-7, CPhI has released its annual report, analyzing key trends and...